Septerna (SEPN) Capital Expenditures (2023 - 2026)
Septerna (SEPN) recorded quarterly Capital Expenditures of $832000.0 in Q1 2026, up 1180.0% quarter-over-quarter from $65000.0 in Q4 2025, and up 117.8% on a YoY basis from $382000.0 in Q1 2025.
Septerna (SEPN) Capital Expenditures (2023 - 2026) Analysis & Trends
Septerna's Capital Expenditures history runs 4 years deep, the most recent figure standing at $832000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures rose 117.8% year-over-year to $832000.0; the TTM figure through Mar 2026 stood at $968000.0 (down 43.75% YoY), while the FY2025 annual figure was $518000.0, down 75.37% from the prior year.
- Capital Expenditures was $832000.0 for Q1 2026 at Septerna, up from $65000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $1.2 million in Q4 2023 to a low of $13000.0 in Q3 2025.
- Historically, Capital Expenditures has averaged $469200.0 across 4 years, with a median of $480000.0 in 2024.
- The sharpest annual moves came in 2025 and 2026: Capital Expenditures slumped 97.75% in 2025, then soared 117.8% in 2026.
- A 4-year view of Capital Expenditures shows it stood at $1.2 million in 2023, then tumbled by 50.61% to $612000.0 in 2024, then tumbled by 89.38% to $65000.0 in 2025, then soared by 1180.0% to $832000.0 in 2026.
- The last three Capital Expenditures figures came in at $832000.0 (Q1 2026), $65000.0 (Q4 2025), and $13000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - | 832,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 832,000.00 |
| Mar 31, 2026 | 832,000.00 |
| Dec 31, 2025 | 65,000.00 |
| Dec 31, 2025 | 65,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Mar 31, 2025 | 382,000.00 |
| Mar 31, 2025 | 382,000.00 |
| Dec 31, 2024 | 612,000.00 |
| Dec 31, 2024 | 612,000.00 |
| Sep 30, 2024 | 578,000.00 |
| Sep 30, 2024 | 578,000.00 |
| Jun 30, 2024 | 149,000.00 |
| Jun 30, 2024 | 149,000.00 |
| Mar 31, 2024 | 764,000.00 |
| Mar 31, 2024 | 764,000.00 |
| Dec 31, 2023 | 1.24 Mn |
| Dec 31, 2023 | 1.24 Mn |